First Clinical Data Of Resminostat, A Novel Oral Histone Deacetylase (Hdac) Inhibitor, In Patients With Hepatocellular Carcinoma (Hcc): The Shelter Study

JOURNAL OF CLINICAL ONCOLOGY(2010)

引用 5|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要